Replies to post #453029 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

More FUD from sumbuysumsell,

"...The hype around the 3-71 schizophrenia trial is amazing to me. This is a 40 patient P2 that hasn't even started. If one considers a larger P3 will likely be needed that could be 8-10 years from now to completion. Nuts.

As for 2-73. Regulatory pathways are still talk. I've seen enough of the can kicking since 2015 to be wary. As an investor and someone who desires progress on AD I hope you are right...."

All just FUD Anavex 3-71 may NOT need a Phase 3 trial for FDA approval. I believe that the results from the Phase 2 trial will be sufficient for FDA approval. Anavex 3-71 is very very potent especially when given TID (three times per day) schizophrenia is a disease/condition with unmet needs.

GOD bless,

[Steady_T]

Lol. Negative Nelly.

If one considers a larger P3 will likely be needed that could be 8-10 years from now to completion. Nuts.